HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 44th ANNUAL GLOBAL HEALTHCARE CONFERENCE

About this update from Harmony Biosciences Holdings, Inc.

[{"type":"text","content":"PLYMOUTH MEETING, Pa., May 30, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (\"Harmony\" or the \"Company\") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA on Tuesday, June 13, 2023, at 2:00 p.m. PT/ 5:00 p.m. ET.\n\n \n \n \n \n \n \n\n \nA webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/. \nAbout Harmony Biosciences\nAt Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.\nHarmony Biosciences Investor Contact:Luis Sanay, [email protected] \nHarmony Biosciences Media Contact:Cate [email protected]\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-goldman-sachs-44th-annual-global-healthcare-conference-301835959.html\nSOURCE Harmony Biosciences","length":3817,"tagName":"div"}]

More updates from Harmony Biosciences Holdings, Inc.